Cabot Corporation $CBT Holdings Increased by Leeward Investments LLC MA

Leeward Investments LLC MA grew its stake in shares of Cabot Corporation (NYSE:CBT) by 12.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 203,616 shares of the specialty chemicals company’s stock after buying an additional 21,997 shares during the quarter. Leeward Investments LLC MA owned about 0.38% of Cabot worth $15,271,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Beverly Hills Private Wealth LLC grew its stake in shares of Cabot by 3.6% in the 1st quarter. Beverly Hills Private Wealth LLC now owns 3,918 shares of the specialty chemicals company’s stock worth $326,000 after purchasing an additional 135 shares during the last quarter. Keeley Teton Advisors LLC grew its stake in shares of Cabot by 1.0% in the 1st quarter. Keeley Teton Advisors LLC now owns 16,756 shares of the specialty chemicals company’s stock worth $1,393,000 after purchasing an additional 174 shares during the last quarter. Isthmus Partners LLC grew its stake in shares of Cabot by 4.6% in the 1st quarter. Isthmus Partners LLC now owns 4,258 shares of the specialty chemicals company’s stock worth $354,000 after purchasing an additional 186 shares during the last quarter. Ferguson Wellman Capital Management Inc. grew its stake in shares of Cabot by 4.2% in the 2nd quarter. Ferguson Wellman Capital Management Inc. now owns 5,000 shares of the specialty chemicals company’s stock worth $375,000 after purchasing an additional 200 shares during the last quarter. Finally, GAMMA Investing LLC grew its stake in shares of Cabot by 12.3% in the 2nd quarter. GAMMA Investing LLC now owns 1,909 shares of the specialty chemicals company’s stock worth $143,000 after purchasing an additional 209 shares during the last quarter. 93.18% of the stock is currently owned by institutional investors.

Cabot Trading Up 0.3%

Shares of CBT stock opened at $71.31 on Friday. Cabot Corporation has a 1 year low of $66.50 and a 1 year high of $117.46. The firm’s fifty day simple moving average is $76.52 and its 200 day simple moving average is $76.48. The firm has a market capitalization of $3.79 billion, a P/E ratio of 9.32 and a beta of 0.88. The company has a current ratio of 2.13, a quick ratio of 1.41 and a debt-to-equity ratio of 0.66.

Cabot (NYSE:CBT) last announced its earnings results on Monday, August 4th. The specialty chemicals company reported $1.90 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.80 by $0.10. The business had revenue of $923.00 million for the quarter, compared to analyst estimates of $957.29 million. Cabot had a net margin of 11.14% and a return on equity of 25.68%. Cabot has set its FY 2025 guidance at 7.150-7.500 EPS. As a group, sell-side analysts predict that Cabot Corporation will post 7.57 EPS for the current year.

Insider Buying and Selling at Cabot

In other news, CEO Sean D. Keohane sold 114,436 shares of the company’s stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $79.28, for a total value of $9,072,486.08. Following the sale, the chief executive officer owned 361,518 shares of the company’s stock, valued at approximately $28,661,147.04. This represents a 24.04% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 3.03% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Mizuho dropped their target price on shares of Cabot from $90.00 to $88.00 and set an “outperform” rating on the stock in a research report on Friday, October 3rd. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a research report on Friday. Finally, UBS Group set a $82.00 price target on shares of Cabot and gave the stock a “neutral” rating in a report on Tuesday, August 5th. One research analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Cabot presently has a consensus rating of “Hold” and a consensus target price of $85.00.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.